Ventas, INC

Ventas, Inc. announced robust second quarter 2026 financial results, driven by significant investment activity and strong performance in its Senior Housing Operating Portfolio, leading to an increase in full-year earnings guidance.

Ventas, Inc. reports the retirement of a key executive and an increase in its at-the-market equity offering program to $3 billion.

Ventas reported strong Q1 2026 results, highlighted by a 15% increase in same-store cash NOI for its senior housing operating portfolio and an upward revision to full-year guidance.

Ventas, Inc. amended its At-The-Market sales agreement, increasing its potential equity offering capacity to $2.5 billion and adding M&T Securities, Inc. as a sales agent.

Ventas, Inc. announced robust fourth quarter and full year 2025 financial results, a significant dividend increase, and a positive outlook for 2026 driven by senior housing growth.

Ventas, Inc. has expanded its unsecured credit facilities by $1.25 billion, increasing its term loan to $700 million and adding a new $550 million delayed draw term loan, while also extending the maturity of its term loan to 2031.

Ventas, Inc. announced its second quarter 2026 financial results, highlighting significant growth in its Senior Housing Operating Portfolio (SHOP) segment, driven by increased occupancy and rental rates.

Ventas, Inc. announced a significant increase in net income and FFO for Q3 and the first nine months of 2025, driven by strong performance across its senior housing and medical property portfolios.

Ventas, Inc. announced a significant increase in net income and FFO for the second quarter and first half of 2025, fueled by robust performance in its senior housing operating portfolio and active capital and portfolio management.

Ventas, Inc. announces its Q1 2025 financial results, showcasing growth in the senior housing operating portfolio (SHOP) and strategic capital allocation.

Ventas Inc. saw a positive third quarter in 2024, driven by growth in its senior housing operating portfolio and strategic capital management.

Ventas Inc. announced its second quarter 2024 results, showing a net income of $5.1 million, impacted by strategic dispositions and increased operating expenses, while also highlighting growth in its senior housing operating portfolio.

Ventas, Inc. reports increased net operating income driven by growth in its senior housing operating portfolio and strategic investments and dispositions.

Ventas, Inc. has updated its policy to allow for the recovery of certain executive compensation following financial restatements due to material noncompliance with financial reporting requirements.

Andy Wattula, EVP OM&R-Ventas/Pres&CEO-LHS of Ventas, Inc., reported multiple transactions in common stock on August 1, 2026.

Maurice S Smith, a Director of Ventas, Inc., reported multiple transactions in common stock on July 16, 2026.

Sumit Roy, a Director of Ventas, Inc., reported multiple transactions in common stock on July 16, 2026.

Marguerite M Nader, a Director of Ventas, Inc., received 72 shares of common stock on July 16, 2026.

Joe Vasquez Rodriguez Jr., a Director of Ventas, Inc., received 49 shares of common stock on July 16, 2026.

Roxanne M Martino, a Director of Ventas, Inc., received 174 shares of common stock on July 16, 2026.

Ventas Inc. issues a supplement to its proxy statement clarifying that the NYSE considers the proposal to increase authorized shares of common stock a 'routine' matter, allowing brokers discretionary voting.

Ventas, Inc. has filed a definitive proxy statement with the SEC.

Ventas reports strong 2024 performance, driven by senior housing growth, and proposes key governance changes at its upcoming annual meeting.

Ventas, Inc. has filed a definitive proxy statement with the SEC.

Ventas, Inc. has released its definitive proxy statement, outlining key proposals for the upcoming annual meeting, including director elections, executive compensation, and auditor ratification, while showcasing the company's strong financial performance and commitment to corporate governance.

Ventas, Inc. reports a single equity holding in Ardent Health, Inc. valued at approximately $79.97 million as of March 31, 2026.

Ventas, Inc. reported a sole investment of $123.8 million in 9.34 million common shares of Ardent Health, Inc. as of September 30, 2025.

Ventas, Inc. reports a $159.6 million investment in Ardent Health Partners as of December 31, 2024.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.7% of Ventas, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 7.1% of Ventas, Inc. common stock as of March 31, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 7.1% of Ventas, Inc. common stock as of March 31, 2026.

Vanguard Capital Management disclosed a beneficial ownership of 7.55% of Ventas Inc. common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 8.69% of Ventas Inc. common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Ventas Inc following an internal realignment.